← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2019

Cost-utility analysis of 21-gene assay for node-positive early breast cancer.

L Masucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31708649